Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Katia Falasca and Claudio Ucciferri.
Katia Falasca
Connection Strength
4.314
Claudio Ucciferri
  1. Parameters associated with diagnosis of COVID-19 in emergency department. Immun Inflamm Dis. 2021 09; 9(3):851-861.
    View in: PubMed
    Score: 0.944
  2. Role of monoclonal antibody drugs in the treatment of COVID-19. World J Clin Cases. 2020 Oct 06; 8(19):4280-4285.
    View in: PubMed
    Score: 0.907
  3. Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients. Mediterr J Hematol Infect Dis. 2020; 12(1):e2020048.
    View in: PubMed
    Score: 0.890
  4. Canakinumab in a subgroup of patients with COVID-19. Lancet Rheumatol. 2020 Aug; 2(8):e457-ee458.
    View in: PubMed
    Score: 0.885
  5. It is Not Always COVID-19: Case Report about an Undiagnosed HIV Man with Dyspnea. Curr HIV Res. 2021; 19(6):548-551.
    View in: PubMed
    Score: 0.230
  6. Air and surface measurements of SARS-CoV-2 inside a bus during normal operation. PLoS One. 2020; 15(11):e0235943.
    View in: PubMed
    Score: 0.228
  7. Efficacy of canakinumab in mild or severe COVID-19 pneumonia. Immun Inflamm Dis. 2021 06; 9(2):399-405.
    View in: PubMed
    Score: 0.116
  8. Normal breathing releases SARS-CoV-2 into the air. J Med Microbiol. 2021 Mar; 70(3).
    View in: PubMed
    Score: 0.058
  9. Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids. Microorganisms. 2020 Aug 31; 8(9).
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.